Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,537 public trials 1,488 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Completed

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

NCT02963831

Conditions
Adnexal Diseases, Appendiceal Cancer, Appendiceal Neoplasms, +27 more
Locations
  • Research Facility San Diego, California, United States
  • Research Facility Miami, Florida, United States
  • Research Facility Buffalo, New York, United States
  • Research Facility New York, United States
View Trial Details
Completed

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

NCT03996369

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • East View Medical Research, LLC Mobile, Alabama, United States
  • Arizona Digestive Health Sun City, Arizona, United States
  • Om Research, LLC Lancaster, California, United States
View all 407 locations
View Trial Details
Completed

Chromogranin A as Blood Marker in Cancer Patients

NCT03817866

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +25 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Charité - Universitätsmedizin Berlin Berlin, Germany
View Trial Details
Completed

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

NCT03945188

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Arizona Digestive Health Sun City, Arizona, United States
  • Om Research, LLC Lancaster, California, United States
  • Entertainment Medical Group, Inc. Los Angeles, California, United States
View all 315 locations
View Trial Details
Completed

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

NCT01416688

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 113 locations
View Trial Details

Related conditions